13 November 2015 - The U.S. FDA today approved Adynovate, antihaemophilic Factor (recombinant), PEGylated for use in adults and adolescents, aged 12 years and older, who have haemophilia A.

For more details, go to: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm472643.htm